[ET Net News Agency, 6 January 2022] Credit Suisse lowered its target price for PA
Gooddoctor (01833) to HK$26.5 from HK$50 and downgraded its rating to "neutral" from
"outperform".
The research house said key downside risks include tougher-than-expected policy,
worse-than-expected e-commerce slowdown, and larger-than-expected net loss impact due to
the development of online medical service capabilities. Key upside risks include
faster-than-expected sales growth in company's core business. (RC)